Guest article by Fiona Godfrey, Consultant in health and climate policy and former Secretary-General at EPHA As we enter the second year of the COVID-19 pandemic, one of the biggest issues we face is how public health priorities interact with civil and human rights. I...
Transparency of (real) pharmaceutical costs 18 January 2022 14:00 - 15:15 CET Online Join the second event of the Zooming in on Solution to the Affordability of Medicines webinar series, co-hosted by the European Alliance for Responsible R&D and Affordable...
The December 2021 Council Conclusions negotiated under the Slovenian Presidency of the EU and signed off by all 27 EU Health Ministers offer a helpful snapshot of where the pharmaceuticals debate stands today, nearly two years into the COVID-19 pandemic and one year...
EPHA’s access to medicines, A2MDialogues series started in the second half of 2020 with five episodes of an-hour long, live, online conversations with key decision-makers shaping medicines’ policies in Europe. The series continued in 2021 with four additional episodes...
As the past 2 years have been dominated by COVID-19, the upcoming revision of the EU pharmaceutical legislation could not come at a more critical time. The pandemic increased the relevance and power of the pharmaceutical industry as a key provider of vaccines and...
